Sunho Biologics: Non-Executive Director Fan Rongkui to Leave Board on 22 July 2026; Trading Remains Suspended

Bulletin Express

Jul 21

Sunho Biologics, Inc. (SUNHO BIO-B) announced that Non-Executive Director Fan Rongkui will step down when his current service contract expires on 22 July 2026. The contract will not be renewed.

Mr. Fan confirmed he has no disagreement with the Board and is unaware of matters requiring shareholder attention, based on information available to him as of the announcement date. He noted that an independent investigation into certain matters is ongoing, and its findings have not yet been released.

The Board stated that Mr. Fan’s departure will not reduce the number of directors below the minimum stipulated in the company’s articles, and the Board will remain fully compliant with Hong Kong Listing Rules.

Trading in Sunho Biologics’ shares has been suspended since 9:00 a.m. on 1 April 2026 and will continue until the release of audited results for the year ended 31 December 2025. Shareholders and potential investors are advised to exercise caution and seek professional advice when dealing in the company’s securities.

As of the announcement date, the Board comprises two Executive Directors (Zhang Feng and Jiang Xiaoling), one Non-Executive Director (Fan Rongkui) and three Independent Non-Executive Directors (Chan Heung Wing Anthony, Feng Lan and Shi Luwen).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1128042351"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1128042351\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1128042351?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-21 23:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128042351","market":"hk","top_or_hot":-1,"title":"Sunho Biologics: Non-Executive Director Fan Rongkui to Leave Board on 22 July 2026; Trading Remains Suspended","media":"Bulletin Express","content":"<p>Sunho Biologics, Inc. (SUNHO BIO-B) announced that Non-Executive Director Fan Rongkui will step down when his current service contract expires on 22 July 2026. The contract will not be renewed.</p>\n<p>Mr. Fan confirmed he has no disagreement with the Board and is unaware of matters requiring shareholder attention, based on information available to him as of the announcement date. He noted that an independent investigation into certain matters is ongoing, and its findings have not yet been released.</p>\n<p>The Board stated that Mr. Fan’s departure will not reduce the number of directors below the minimum stipulated in the company’s articles, and the Board will remain fully compliant with Hong Kong Listing Rules.</p>\n<p>Trading in Sunho Biologics’ shares has been suspended since 9:00 a.m. on 1 April 2026 and will continue until the release of audited results for the year ended 31 December 2025. Shareholders and potential investors are advised to exercise caution and seek professional advice when dealing in the company’s securities.</p>\n<p>As of the announcement date, the Board comprises two Executive Directors (Zhang Feng and Jiang Xiaoling), one Non-Executive Director (Fan Rongkui) and three Independent Non-Executive Directors (Chan Heung Wing Anthony, Feng Lan and Shi Luwen).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sunho Biologics: Non-Executive Director Fan Rongkui to Leave Board on 22 July 2026; Trading Remains Suspended</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSunho Biologics: Non-Executive Director Fan Rongkui to Leave Board on 22 July 2026; Trading Remains Suspended\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-21 23:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sunho Biologics, Inc. (SUNHO BIO-B) announced that Non-Executive Director Fan Rongkui will step down when his current service contract expires on 22 July 2026. The contract will not be renewed.</p>\n<p>Mr. Fan confirmed he has no disagreement with the Board and is unaware of matters requiring shareholder attention, based on information available to him as of the announcement date. He noted that an independent investigation into certain matters is ongoing, and its findings have not yet been released.</p>\n<p>The Board stated that Mr. Fan’s departure will not reduce the number of directors below the minimum stipulated in the company’s articles, and the Board will remain fully compliant with Hong Kong Listing Rules.</p>\n<p>Trading in Sunho Biologics’ shares has been suspended since 9:00 a.m. on 1 April 2026 and will continue until the release of audited results for the year ended 31 December 2025. Shareholders and potential investors are advised to exercise caution and seek professional advice when dealing in the company’s securities.</p>\n<p>As of the announcement date, the Board comprises two Executive Directors (Zhang Feng and Jiang Xiaoling), one Non-Executive Director (Fan Rongkui) and three Independent Non-Executive Directors (Chan Heung Wing Anthony, Feng Lan and Shi Luwen).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02898","symbol_name":"盛禾生物-B","start_time":0,"source_url":"","article_id":"1128042351","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128042351","pubTimestamp":1784646040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sunho Biologics, Inc. (SUNHO BIO-B) announced that Non-Executive Director Fan Rongkui will step down when his current service contract expires on 22 July 2026. The contract will not be renewed. Mr....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02898":"盛禾生物-B"},"translate_title":"Sunho Biologics：非执行董事范荣奎将于2026年7月22日离开董事会；交易仍暂停","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02898":1},"content_text":"Sunho Biologics, Inc. (SUNHO BIO-B) announced that Non-Executive Director Fan Rongkui will step down when his current service contract expires on 22 July 2026. The contract will not be renewed.\nMr. Fan confirmed he has no disagreement with the Board and is unaware of matters requiring shareholder attention, based on information available to him as of the announcement date. He noted that an independent investigation into certain matters is ongoing, and its findings have not yet been released.\nThe Board stated that Mr. Fan’s departure will not reduce the number of directors below the minimum stipulated in the company’s articles, and the Board will remain fully compliant with Hong Kong Listing Rules.\nTrading in Sunho Biologics’ shares has been suspended since 9:00 a.m. on 1 April 2026 and will continue until the release of audited results for the year ended 31 December 2025. Shareholders and potential investors are advised to exercise caution and seek professional advice when dealing in the company’s securities.\nAs of the announcement date, the Board comprises two Executive Directors (Zhang Feng and Jiang Xiaoling), one Non-Executive Director (Fan Rongkui) and three Independent Non-Executive Directors (Chan Heung Wing Anthony, Feng Lan and Shi Luwen).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}